FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2075884078> ?p ?o ?g. }

• W2075884078 endingPage "e36001" @default.
• W2075884078 startingPage "e36001" @default.
• W2075884078 abstract "Background Regimens for isoniazid-based preventive therapy (IPT) for tuberculosis (TB) in HIV-infected individuals have not been widely adopted given concerns regarding efficacy, adherence and drug resistance. Further, the cost-effectiveness of IPT has not been studied in India. Methods We used an HIV/TB model to project TB incidence, life expectancy, cost and incremental cost-effectiveness of six months of isoniazid plus ethambutol (6EH), thirty-six months of isoniazid (36H) and no IPT for HIV-infected patients in India. Model input parameters included a median CD4 count of 324 cells/mm3, and a rate ratio of developing TB of 0.35 for 6EH and 0.22 for 36H at three years as compared to no IPT. Results of 6EH and 36H were also compared to six months of isoniazid (6H), three months of isoniazid plus rifampin (3RH) and three months of isoniazid plus rifapentine (3RPTH). Results Projected TB incidence decreased in the 6EH and 36H regimens by 51% and 62% respectively at three-year follow-up compared to no IPT. Without IPT, projected life expectancy was 136.1 months at a lifetime per person cost of $5,630. 6EH increased life expectancy by 0.8 months at an additional per person cost of $100 (incremental cost-effectiveness ratio (ICER) of $1,490/year of life saved (YLS)). 36H further increased life expectancy by 0.2 months with an additional per person cost of $55 (ICER of $3,120/YLS). The projected clinical impact of 6EH was comparable to 6H and 3RH; however when compared to these other options, 6EH was no longer cost-effective given the high cost of ethambutol. Results were sensitive to baseline CD4 count and adherence. Conclusions Three, six and thirty-six-month regimens of isoniazid-based therapy are effective in preventing TB. Three months of isoniazid plus rifampin and six-months of isoniazid are similarly cost-effective in India, and should be considered part of HIV care." @default.
• W2075884078 created "2016-06-24" @default.
• W2075884078 creator A5002686651 @default.
• W2075884078 creator A5019522183 @default.
• W2075884078 creator A5024307678 @default.
• W2075884078 creator A5025150770 @default.
• W2075884078 creator A5025969621 @default.
• W2075884078 creator A5073643745 @default.
• W2075884078 creator A5074313423 @default.
• W2075884078 creator A5076624513 @default.
• W2075884078 creator A5078419406 @default.
• W2075884078 creator A5081410269 @default.
• W2075884078 date "2012-04-30" @default.
• W2075884078 modified "2023-09-23" @default.
• W2075884078 title "The Cost-Effectiveness of Tuberculosis Preventive Therapy for HIV-Infected Individuals in Southern India: A Trial-Based Analysis" @default.
• W2075884078 cites W1920771564 @default.
• W2075884078 cites W1967223378 @default.
• W2075884078 cites W1982334998 @default.
• W2075884078 cites W1990507589 @default.
• W2075884078 cites W2002935662 @default.
• W2075884078 cites W2007639864 @default.
• W2075884078 cites W2015386250 @default.
• W2075884078 cites W2021860584 @default.
• W2075884078 cites W2025298237 @default.
• W2075884078 cites W2041542511 @default.
• W2075884078 cites W2057578063 @default.
• W2075884078 cites W2067528418 @default.
• W2075884078 cites W2074275903 @default.
• W2075884078 cites W2077022265 @default.
• W2075884078 cites W2078908246 @default.
• W2075884078 cites W2082349840 @default.
• W2075884078 cites W2095749895 @default.
• W2075884078 cites W2109173191 @default.
• W2075884078 cites W2121709759 @default.
• W2075884078 cites W2128463605 @default.
• W2075884078 cites W2130718830 @default.
• W2075884078 cites W2131044206 @default.
• W2075884078 cites W2148232746 @default.
• W2075884078 cites W2166092946 @default.
• W2075884078 cites W2166112014 @default.
• W2075884078 cites W2169275182 @default.
• W2075884078 cites W2171141994 @default.
• W2075884078 doi "https://doi.org/10.1371/journal.pone.0036001" @default.
• W2075884078 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3340407" @default.
• W2075884078 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22558301" @default.
• W2075884078 hasPublicationYear "2012" @default.
• W2075884078 type Work @default.
• W2075884078 sameAs 2075884078 @default.
• W2075884078 citedByCount "29" @default.
• W2075884078 countsByYear W20758840782014 @default.
• W2075884078 countsByYear W20758840782015 @default.
• W2075884078 countsByYear W20758840782016 @default.
• W2075884078 countsByYear W20758840782017 @default.
• W2075884078 countsByYear W20758840782018 @default.
• W2075884078 countsByYear W20758840782020 @default.
• W2075884078 countsByYear W20758840782021 @default.
• W2075884078 crossrefType "journal-article" @default.
• W2075884078 hasAuthorship W2075884078A5002686651 @default.
• W2075884078 hasAuthorship W2075884078A5019522183 @default.
• W2075884078 hasAuthorship W2075884078A5024307678 @default.
• W2075884078 hasAuthorship W2075884078A5025150770 @default.
• W2075884078 hasAuthorship W2075884078A5025969621 @default.
• W2075884078 hasAuthorship W2075884078A5073643745 @default.
• W2075884078 hasAuthorship W2075884078A5074313423 @default.
• W2075884078 hasAuthorship W2075884078A5076624513 @default.
• W2075884078 hasAuthorship W2075884078A5078419406 @default.
• W2075884078 hasAuthorship W2075884078A5081410269 @default.
• W2075884078 hasBestOaLocation W20758840781 @default.
• W2075884078 hasConcept C112930515 @default.
• W2075884078 hasConcept C120665830 @default.
• W2075884078 hasConcept C121332964 @default.
• W2075884078 hasConcept C126322002 @default.
• W2075884078 hasConcept C133925201 @default.
• W2075884078 hasConcept C141071460 @default.
• W2075884078 hasConcept C142724271 @default.
• W2075884078 hasConcept C187212893 @default.
• W2075884078 hasConcept C2776228421 @default.
• W2075884078 hasConcept C2776688490 @default.
• W2075884078 hasConcept C2776967927 @default.
• W2075884078 hasConcept C2776991065 @default.
• W2075884078 hasConcept C2777975735 @default.
• W2075884078 hasConcept C2779806340 @default.
• W2075884078 hasConcept C2781069245 @default.
• W2075884078 hasConcept C2908647359 @default.
• W2075884078 hasConcept C3019080777 @default.
• W2075884078 hasConcept C515549039 @default.
• W2075884078 hasConcept C61511704 @default.
• W2075884078 hasConcept C71924100 @default.
• W2075884078 hasConcept C99454951 @default.
• W2075884078 hasConceptScore W2075884078C112930515 @default.
• W2075884078 hasConceptScore W2075884078C120665830 @default.
• W2075884078 hasConceptScore W2075884078C121332964 @default.
• W2075884078 hasConceptScore W2075884078C126322002 @default.
• W2075884078 hasConceptScore W2075884078C133925201 @default.
• W2075884078 hasConceptScore W2075884078C141071460 @default.
• W2075884078 hasConceptScore W2075884078C142724271 @default.
• W2075884078 hasConceptScore W2075884078C187212893 @default.
• W2075884078 hasConceptScore W2075884078C2776228421 @default.

• next